A Common CD36 Variant Influences Endothelial Function and Response to Treatment with Phosphodiesterase 5 Inhibition.

Shibao CA, Celedonio JE, Ramirez CE, Love-Gregory L, Arnold AC, Choi L, Okamoto LE, Gamboa A, Biaggioni I, Abumrad NN, Abumrad NA
J Clin Endocrinol Metab. 2016 101 (7): 2751-8

PMID: 27144937 · PMCID: PMC4929841 · DOI:10.1210/jc.2016-1294

MeSH Terms (18)

Adult Cardiovascular Diseases Case-Control Studies CD36 Antigens Drug Resistance Endothelium, Vascular Female Genetic Predisposition to Disease Humans Insulin Resistance Metabolic Syndrome Middle Aged Obesity Phosphodiesterase 5 Inhibitors Polymorphism, Single Nucleotide Sildenafil Citrate Treatment Outcome Vasodilation

Connections (1)

This publication is referenced by other Labnodes entities:

Links